Ligand Pharmaceuticals Inc (NASDAQ:LGND)

137.38
Delayed Data
As of Oct 25
 +0.66 / +0.48%
Today’s Change
78.26
Today|||52-Week Range
219.75
+38.14%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 190.00, with a high estimate of 310.00 and a low estimate of 170.00. The median estimate represents a +38.30% increase from the last price of 137.38.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$1.04
Sales
$56.3M
Reporting Date
Nov 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -36.40%
 
 
 
 
 
 
Growthannually 30.26%
 
 
 
 
 
 

Sales

Growthquarterly -33.55%
 
 
 
 
 
 
Growthannually 44.72%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.